Ezetrol · DIN 02247521 · 10 mg · tablet
Limited Use, Reason for Use code 380, 381 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 380, 381 required
Write on scriptone applicable Reason for Use code, 380 or 381 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 380, 381
Reason for Use code 380
For use in combination with a HMG-CoA reductase inhibitor ('statin') in patients with hypercholesterolemia who have not reached target LDL levels despite the use of maximally tolerated doses.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 381
For use as monotherapy in the management of hypercholesterolemia in patients who are intolerant to HMG-CoA reductase inhibitors or where HMG-CoA reductase inhibitors are contraindicated.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: RxHelp ONE lists Ezetrol (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Ezetrol · DIN 02247521
Manufacturer: Organon Canada Inc.; listing date 2004-04-06
Health Canada: Marketed since 2022-04-22 · brand EZETROL · ATC C10AX09 EZETIMIBE · form Tablet · route Oral · ingredients EZETIMIBE 10 MG · company Organon canada inc. · schedule Prescription
Ministry pays: $0.1811 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02247521)
Source record
DIN 02247521: Ezetrol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240600049; group id 302; item number 0656; lccId 00150; manufacturer id OCI
Source form: Tab; strength: 10mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $2.2508; ministry $0.1811
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02247521
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71771
Interchangeable products
AG-Ezetimibe · DIN 02475898 · $0.1811
Ach-Ezetimibe · DIN 02425610 · $0.1811
Act Ezetimibe · DIN 02414716 · $0.1811
Apo-Ezetimibe · DIN 02427826 · $0.1811
Auro-Ezetimibe · DIN 02469286 · $0.1811
Bio-Ezetimibe · DIN 02425211 · $0.1811
Ezetimibe · DIN 02429659 · $0.1811
Ezetimibe · DIN 02431300 · $0.1811
GLN-Ezetimibe · DIN 02460750 · $0.1811
Jamp-Ezetimibe · DIN 02423235 · $0.1811
M-Ezetimibe · DIN 02467437 · $0.1811
Mar-Ezetimibe · DIN 02422662 · $0.1811
Mint-Ezetimibe · DIN 02423243 · $0.1811
NRA-Ezetimibe · DIN 02481669 · $0.1811
NRA-Ezetimibe Tablets · DIN 02536420 · $0.1811
PMS-Ezetimibe · DIN 02416409 · $0.1811
Ran-Ezetimibe · DIN 02419548 · $0.1811
Sandoz Ezetimibe · DIN 02416778 · $0.1811
Teva-Ezetimibe · DIN 02354101 · $0.1811
Shortage status: not checked (no credentials)